AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. EBITDA margin (%)

JCR Pharmaceuticals Co.,Ltd.【JP:4552】

Market cap
¥90B
P/E ratio
52.9x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 2025-9.9-139.58%
Mar 31, 202425+23.26%
Mar 31, 202320.3-52.60%
Mar 31, 202242.8+26.81%
Mar 31, 202133.8+78.91%
Mar 31, 202018.9-30.71%
Mar 31, 201927.2+8.61%
Mar 31, 201825.1+19.09%
Mar 31, 201721.1+3.17%
Mar 31, 201620.4+2.21%
Mar 31, 201520

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)